Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precancerous Conditions 4Colorectal Neoplasms 4Breast Neoplasms 4Adenomatous Polyposis Coli 4Neoplasms 3Colonic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Unspecified Adult Solid Tumor, Protocol Specific 1Tobacco Use Disorder 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Melanoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Desmoid Tumors 1Coproporphyria 1Colonic Polyps 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Aberrant Crypt Foci 1

Interventions

nirogacestat 6Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3X-Rays 2Toremifene 2Phantoms, Imaging 2Cryosurgery 2Blood Specimen Collection 2vactosertib 1trifluridine tipiracil drug combination 1strattice 1liposomal doxorubicin 1entinostat 1anlotinib 1Vinblastine 1Taxes 1Tamoxifen 1Sunitinib 1Sulindac 1Sorafenib 1Sirolimus 1Saline Solution 1Radiotherapy 1Radiofrequency Ablation 1Oxaliplatin 1Methotrexate 1Leucovorin 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Desmoid Tumors × Sulindac × Clear all
NCT00068419 2020-02-19

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Children's Oncology Group

Phase 2 Completed
70 enrolled 11 charts
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡